Introduction
HIV-I may be transmitted from an infected mother to her fetus during pregnancy or childbirth. '4 Various studies estimate that about 20-50% of infants born of infected mothers are also infected. 56 We studied the incidence of vertical transmission of HIV-I in Lusaka, Zambia, and the possible risks of immunising potentially infected infants with attenuated vaccines.
Patients and methods
During February to May 1987 May , 1954 consecutive women delivering at this hospital were entered in the study. We obtained detailed histories after getting informed consent and performed a thorough physical examination and collected 3-5 ml venous blood. Cord blood was taken from live and stillborn infants. The serum samples of mother, baby, and, in some cases, the father were tested for antibodies to HIV-I by enzyme linked immunosorbent assay (ELISA) and western blot analysis. We attempted to trace and follow up two groups: (a) all women positive for antibody to HIV-I and their infants and (b) 40 sets of women negative for antibody to HIV-I and their infants. All seropositive women and their spouses were counselled. Repeat venous blood samples were collected from mothers and infants in both the groups at 6-8, 12, 18 , and 24 months and tested for antibodies to HIV and a complete blood count was done. All children received vaccines: BCG at birth, oral polio and diphtheria, pertussis, and tetanus at 3, 4, and 5 months, and measles at 8 months.
Data were analysed by using X2 tests with epidemiologic software from the Centers for Disease Control.
Results
Of 1954 women screened at delivery, 227 (12%) were seropositive for HIV-I. The seropositive women were significantly younger with a mean (SD) age of (5-4) years (Student's t test p<005). The seronegative women had a mean (SD) age of 25-1 (7-7) years. Among seropositive women, 62 (27%) were primigravidas and 185 (82%) were married. Risk cofactors such as higher number of lifetime sexual partners (table I), single or divorced or widowed, higher  educational state (table II), history of transfusion,  travel abroad, and working (table III) were associated with high seroprevalence of HIV-I. Fifty two (23%) of the seropositive women had adverse outcomes compared with 227 (13%) of the seronegative women (p<0 001) (table IV) . This difference, however, was due mainly to the high number of low birthweight infants born to seropositive mothers (odds ratio= 3 75; 95% confidence interval 2 15 to 6 53).
At labour none of the 109 seropositive mothers for whom follow up was possible had AIDS, 17 (16%) had AIDS related complex, 41 (38%) had generalised lymphadenopathy, and the remaining 51 had no symptoms. Subsequently, during two years of follow up, four (4%) developed AIDS, 30 (27) For all variables p>005. mothers who did not infect their children were 30 (p<0-001). Among the transmitters there was a trend for them to be more ill at the time of delivery and during the subsequent follow up of two years (table  VI) .
After we excluded stillbirths 205 specimens of cord blood from infants born to seropositive women were available for testing and 192 (94%) proved positive for antibody to HIV-I. Only 109 out of 205 (53%) sets of seropositive mothers and children were followed for two years. Of 61 children who became seronegative at 8 months, antibodies to HIV-I reappeared in nine at 12 months (figure). By comparison none of the nine children who became seronegative at 12 months showed a reappearance of antibodies. On the other hand, four out of 22 (18%) children who were seropositive up to 12 months became negative at 18 months and were free of symptoms after 24 months. Hence passively transferred antibodies to HIV-I probably persisted in these children up to 18 months. Interestingly, of 13 neonates who were seronegative at birth, four (31 %) converted to become seropositive at different ages: two seroconverted by 8 months, one converted between 8 and 12 months, and one between 12 and 19 months.
The important clinical features among the infected children during the first year of life were pneumonia and recurrent cough. During the second year the features were failure to thrive, recurrent diarrhoea, recurrent fever, lymphadenopathy, pneumonia, and candidiasis (table VII) .
During the longitudinal follow up of children 18 died before 8 months of age; 14 had clinical features of AIDS7 and were seropositive at birth. The remaining four deaths occurred in children who were seronegative at birth; three had gastroenteritis and one had pneumonia. Subsequent follow up showed that by two years another five infected children had died (one, three, and one at 10, 16-18, and 23 months, respectively), four were terminally ill (two with miliary tuberculosis), 17 had AIDS related complex, and two had no symptoms. Thus, including 14 children who had died from clinical AIDS before 8 
Discussion
This study documents the high risk of vertical transmission of HIV-I. The significant difference in adverse outcomes of pregnancy between infected and non-infected mothers was primarily related to low birth weight (table IV) . The infected mothers were 2 9 times more likely to deliver low birthweight babies. The transmission, disease, and mortality in infected children was higher than that reported in the European collaborative study.8 Interestingly, younger women and those with progressive HIV related illness were more effecient transmitters of infection through the perinatal route. One of our important findings was that over two thirds of the children born to seropositive women escaped infection despite being breast fed for 15 to 18 months. Although possible transmission in breast milk has been reported (S Hira, unpublished 
